Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that…
Medical - Instruments & Supplies
CA, Vaughan [HQ]
Ratios
6 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross Margin | 64.17 | 64.88 | 62.34 | 61.04 | 59.69 | 60.40 | |
| Profit Margin | 19.37 | 7.89 | -0.50 | 4.83 | 0.40 | -6.27 | |
| Operating Margin | 11.35 | 14.08 | 7.62 | 8.74 | 5.49 | 3.14 | |
|
EPS Growth
|
- - | -58.13 | -105.72 | 1,169.96 | -91.75 | -1,824.94 | |
| EPS USD | 203.00 | 85.00 | -4.86 | 52.00 | 4.29 | -74.00 | |
| Return on Assets (ROA) | - - | 2.60 | -0.15 | 1.68 | 0.13 | -1.93 | |
| Return on Equity (ROE) | - - | 2.99 | -0.17 | 1.95 | 0.21 | -3.80 | |
| Return on Invested Capital (ROIC) | - - | 4.02 | -0.15 | 2.11 | 0.45 | 1.70 | |
| Solvency | |||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 0.81 | 0.90 | 1.04 | 21.86 | 33.94 | |
| Debt/Equity | - - | 0.93 | 1.02 | 1.20 | 34.64 | 66.60 | |
| Debt/EBITDA | - - | -9.89 | -18.27 | -7.90 | 455.58 | 703.99 | |
|
Debt/Capitalization
|
- - | 0.93 | 1.01 | 1.19 | 25.73 | 39.98 | |
| Long-Term Debt/Capitalization | - - | 0.77 | 0.83 | 0.98 | 25.53 | 39.82 | |
| Interest Debt per Share USD | - - | 0.27 | 0.29 | 0.32 | 7.38 | 13.82 | |
| Debt Growth | - - | - - | 8.60 | 10.89 | 2,075.00 | 87.27 | |
| Liquidity | |||||||
| Current Ratio | - - | 163.77 | 181.96 | 148.77 | 164.89 | 173.65 | |
| Quick Ratio | - - | 87.44 | 97.14 | 81.44 | 83.18 | 74.10 | |
| Cash Ratio | - - | 18.55 | 26.18 | 15.83 | 27.31 | 20.96 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||
| Inventory Turnover | - - | 224.16 | 208.60 | 256.47 | 241.88 | 159.73 | |
| Receivables Turnover | - - | 529.87 | 528.99 | 522.19 | 520.44 | 494.16 | |
| Payables Turnover | - - | 506.49 | 721.91 | 613.81 | 410.54 | 314.56 | |
|
Asset Turnover
|
- - | 32.94 | 30.29 | 34.79 | 33.81 | 30.84 | |
| Fixed Turnover | - - | 378.94 | 293.13 | 307.35 | 289.85 | 298.27 | |
| Coverage | |||||||
| Interest Coverage | 5,200.00 | - - | - - | - - | 141.78 | 45.94 | |
| Asset Coverage | - - | 8,100 | 7,700 | 6,600 | 300 | 100 | |
| Cash Flow Coverage (CFGR) | - - | 859.14 | 516.83 | 779.46 | 14.16 | -0.37 | |
| EBITDA Coverage | 11,600 | - - | - - | - - | 300 | 200 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | |||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 10.14 | 4.26 | -0.24 | 2.60 | 0.28 | -4.35 | |
|
Price/Earnings (P/E)
|
985.92 | 2,348.99 | -41,176.47 | 3,846.15 | 36,190.00 | -2,299.82 | |
| Price/Earnings Growth (PEG) | - - | -40.41 | 389.49 | -3.29 | -394.44 | 1.26 | |
|
Price/Book (P/B)
|
- - | 70.29 | 70.58 | 75.03 | 77.19 | 87.29 | |
| Price/Tangible Book (P/TB) | - - | 70.29 | 70.58 | 75.03 | 77.19 | 87.29 | |
| Price/Sales (P/S) | 191.00 | 185.28 | 205.16 | 185.92 | 144.07 | 144.22 | |
|
Price/Cash Flow (P/CF)
|
917.43 | 876.10 | 1,341.00 | 801.83 | 1,573.48 | -35,173.71 | |
| Price/Free CF (P/FCF) | 1,057.40 | 1,130.86 | 2,661.60 | 1,054.22 | 3,193.24 | -3,019.96 | |
| Price/Operating CF (P/OCF) | 917.43 | 876.10 | 1,341.00 | 801.83 | 1,573.48 | -35,173.71 |